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Objectives: Typhoid fever caused by Salmonella Typhi remains a major burden worldwide. Gastrointestinal 
bleeding can be seen in up to 10 percent of patients and may be fatal. The coagulopathy, which may be 
the driver of this severe complication in patients with typhoid fever, however is ill deﬁned. The aim of 
this study was to evaluate the activation of coagulation, anticoagulation, and ﬁbrinolysis in patients with 
acute typhoid fever. 
Methods: Parameters of coagulation and ﬁbrinolysis were measured in 28 hospitalized patients with 
culture-conﬁrmed or PCR-conﬁrmed typhoid fever and compared to 38 age- and sex-matched healthy 
volunteers. 
Results: Patients demonstrated activation of the coagulation system, as reﬂected by elevated in vitro 
thrombin generation and high plasma levels of ﬁbrinogen, D-dimer and prothrombin fragment F1 + 2 
in concert with consumption of coagulation factors resulting in a prolonged prothrombin-time and 
activated-partial-thromboplastin-time. Concurrently, the anticoagulant proteins, protein C and antithrom- 
bin, were signiﬁcantly lower in comparison to healthy controls. Patients also demonstrated evidence of 
activation and inhibition of ﬁbrinolysis and a marked activation of endothelial cells. The extent of coag- 
ulation activation was associated with the course of the disease, repeated testing during convalescence 
showed a return toward normal values. 
Conclusions: Activation of coagulation is an important clinical feature of typhoid fever and is associated 
with severity of disease. 
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Typhoid fever is a systemic disease caused by the Gram-
egative bacteria Salmonella (S.) enterica serovar Typhi that consti-
utes a global problem with an estimated 21 million cases annually
esulting in over 220,0 0 0 deaths. 1–3 Patients with typhoid fever
sually present with protracted high grade fever, and characteris-
ically a normal to low white blood cell and platelet count. 4 Gas-
rointestinal bleeding has been previously described as the most
ommon complication in typhoid fever, occurring in up to 10 per-
ent of patients. 5 In the majority of cases, the bleeding is minimal
nd resolves without the need for intervention. 6 In a small per-
entage of cases however bleeding is signiﬁcant and can become
atal, 7 however more recent data is lacking on the actual incidence
n intestinal hemorrhage and the case fatality rate. 
Our understanding of the underlying mechanisms responsible
or gastrointestinal bleeding and the role of the coagulation system
nd ﬁbrinolysis in the pathogenesis of typhoid fever is limited. The
xtent of disseminated intravascular coagulation (DIC), which is
haracterized by widespread activation of coagulation resulting in
ntravascular formation of ﬁbrin, 8 has been proposed as a marker
f disease severity in typhoid fever. 9 , 10 Conversely, others have re-
orted that DIC is mostly a subclinical event and found bleeding
omplications in typhoid fever to be uncommon. Notably, in terms
f blood coagulation, it has been suggested that circulating bacte-
ia and endotoxin do not play an important role in typhoid fever
athogenesis. 11 Interestingly, preclinical work has recently identi-
ed a new virulence factor of S. Typhi - called Typhi chimaeric
 2 B 5 typhoid toxin or exotoxin - which is thought to contribute
o the acute symptomatology in patients with typhoid fever by ac-
ivation of, among other factors, vascular endothelial cells. 12 
The aim of this study was to obtain new insights into the
athogenesis of typhoid fever by deﬁning the involvement of the
oagulation, endothelium and ﬁbrinolytic systems in patients hos-
italized with this infection. In addition to the endothelium, we
ocused on the three major pathways – procoagulant, anticoag-
lant, and ﬁbrinolytic – that together determine the overall bal-
nce of clot formation and resolution. Furthermore, we investi-
ated whether the extent of coagulation activation correlated with
 positive blood culture and the presence of disease complications.
aterials and methods 
thical statement 
The study protocol was approved by the National Re-
earch Ethics Committee (NREC) of Bangladesh (BMRC/NREC/2010-
013/1543) and the Oxford Tropical Research Ethics committee
OXTREC-reference 25-11). 
atients and study design 
In order to include patients hospitalized with typhoid fever, we
erformed a prospective all-cause fever study from January 2012
hrough June 2012 in Chittagong Medical College Hospital in Chit-
agong, Bangladesh as previously described. 13–15 Consecutive pa-
ients ( ≥16 years of age) who were admitted with an acute febrile
llness (documented fever ≥38 °C axillary, up to 48 hours after ad-
ission, history of fever less than 2 weeks) were recruited after
iving informed written consent. History and physical examination
ndings were recorded; baseline complete blood counts, renal and
iver functions tests were analyzed. Blood serum, urine, and feces
amples were obtained at admission and day 10 post fever onset
r at hospital discharge and stored at −20 °C. Plasma was prepared
rom blood collected in EDTA and citrate tubes (BD vacutainer ®)
nd stored immediately at −70 °C pending analysis. Blood culturest admission were performed by inoculating 8–10 mL of blood
nto BacT/ALERT FA blood culture bottles and incubated in the
acT/ALERT automated system (Biomerieux) for 5 days. Positive
ottles were processed by standard microbiological methods. If the
ram-stain showed Gram-negative bacilli, blood culture ﬂuid was
ested for S. Typhi and was identiﬁed using API biochemical testing
Biomerieux) and speciﬁc antisera (BioRad). Bacterial isolates were
tored on agar slopes and couriered to Oxford University Clinical
esearch Unit (OUCRU) in Ho Chi Minh City, Vietnam for conﬁr-
ation of identiﬁcation. Real-time PCR was performed on stored
lood, urine and feces samples targeting STY0201 (Putative ﬁmbrial
dhesion in S. Typhi CT18) or SSPA2308 (hypothetical protein in SPA
KU-12601) as described. 16 
A diagnosis of typhoid fever was conﬁrmed if S. Typhi was iso-
ated from the blood culture and/or the real-time PCR indicated the
resence of S. Typhi targets in blood, urine or feces. Complicated
yphoid fever was deﬁned if one or more of the following were
resent: gastrointestinal bleeding (the presence of visible blood
n the stool); intestinal perforation; encephalopathy (delirium, ob-
undation or coma); hemodynamic shock; renal impairment (cre-
tinine level > 2.0 mg/dL); hepatitis (as indicated by AST or ALT
evel ≥10 0 0 U/L); pneumonia (respiratory symptoms with abnor-
al chest X-ray shadowing) or pleural effusion; the presence of
 focal septic complication; severe anemia (hematocrit ≤20%), the
eed for a blood transfusion and death in hospital. 5 , 7 Thrombocy-
openia was deﬁned as a platelet count of < 100 ×10 9 /L. 
38 Bangladeshi volunteers who were known to have no illness
hat could affect hemostasis and were not currently receiving any
edication served as healthy controls. 
ssays 
Stored ETDA and citrated plasma were stored at −80 °C except
hen transferred on dry ice to the Academic Medical Center, Am-
terdam for the coagulation related assays. Prothrombin time (PT),
ctivated partial thromboplastin time (APTT), antithrombin (AT)
nd D-dimer were assayed on an automated blood coagulation an-
lyzer (BCS ® XP, Siemens). Fibrinogen levels were derived from the
hange in optical signal in the PT. Prothrombin fragment F1 + 2
F1 + 2) (Enzygnost ®, Siemens), plasmin-alpha2-antiplasmin com-
lexes (PAPc; DRG Diagnostics), soluble form of the urokinase-type
lasminogen activator receptor (suPAR; suPARgnostics ®, Virogates),
ndothelial cell speciﬁc molecule (ESM) −1/Endocan (Lunginnov),
lasminogen activator inhibitor (PAI) −1 and tissue-type plasmino-
en activator (tPA) (Biomed) were determined by enzyme-linked
mmunosorbent assays (ELISA). 17 , 18 Von Willebrand factor (VWF,
ercentages) and total protein S levels were determined with in-
ouse ELISAs (using antibodies from Dako). 19 Free protein S was
easured by precipitating the C4b-binding protein-bound fraction
ith polyethylene glycol 80 0 0, then measuring the concentration
f free protein S in the supernatant. Protein C was assayed by
inetic assay (Coamatic ®, Chromogenix TM ). Of note, AT and tPA
ere only measured in the blood culture-positive sub-set of pa-
ients due to limited volumes of plasma collected on day of en-
olment. In vitro thrombin generation with 5 pM tissue factor and
ssociated measures (lag time, peak, time-to-peak, area-under-the-
urve (or endogenous thrombin potential (ETP), and velocity index)
ere assayed with the Calibrated Automated Thrombogram ® (Flu-
roskan Ascent, ThermoLab systems) and Thrombinoscope ® soft-
are (Thrombinoscope BV). 18 , 20 Resistance to activated protein C
APC) was determined by testing the effect of APC (Enzyme Re-
earch Laboratories) on the endogenous thrombin potential (ETP)
ith the CAT assay. APC-sensitivity of each plasma sample was de-
ermined in both the presence and absence of ∼4 nM APC. APC
oncentrations used were adjusted to maintain a residual throm-
in generation activity of ∼10% in normal pooled plasma. The
62 H.K. de Jong et al. / Journal of Infection 77 (2018) 60–67 
Table 1 
Baseline information for 28 patients with typhoid fever, comparing culture-positive and culture-negative groups. 
Characteristic Healthy controls ( n = 38) All ( n = 28) P value a Patients with typhoid fever 
Culture negative for 
S. Typhi ( n = 17) 
Culture positive for 
S. Typhi ( n = 11) 
P value b 
Age, years 33.5 (19–55) 28 (20–45) NS 31 (20–45) 25 (20–45) NS 
Male sex, no. (%) of patients 19 (50) 16 (57) NS 10 (59) 6 (55) NS 
Fever duration before admission, days 0 (0–1) 7 (1–15) < 0.0 0 01 5 (1–15) 7 (4–14) NS 
Duration of admission, days 0 (0–0) 5 (0–12) < 0.0 0 01 4 (0–10) 5 (0–12) NS 
Temperature (Celsius, axillary) 36.1 (33.8–37.4) 38.8 (38–40.1) < 0.0 0 01 38.9 (38–39.9) 38.6 (38.3–40.1) NS 
Systolic blood pressure, mmHg 120 (106–169) 116 (85–159) .01 118 (90–140) 111 (85–195) NS 
Pulse, beats/min 72.5 (40–120) 104 (70–150) < 0.0 0 01 96 (70–120) 110 (89–150) .04 
Blood urea nitrogen, mg/dL 6–20 c 12.5 (9.3–76) – 12.8 (10–76) 12 (9.3–15) NS 
Serum creatinine level, mg/dL 0.1–0.5 c 0.9 (0.6–2.2) – 0.9 (0.7–2.2) 0.9 (0.6–1.3) NS 
Aspartate aminotransferase level, U/L < 40 c 40 (13–1430) – 31 (13–1430) 80 (37–450) NS 
Alanine aminotransferase level, U/L < 45 c 49 (15–1199) – 33 (15–1199) 60 (24–220) NS 
Hemoglobin level, g/dl 13.3 (8.4–15.5) 12.1 (3.5–14.5) .002 12 (3.5–14.4) 12.4 (7.5–14.5) NS 
WBC count, x10 9 cells/L 7.5 (4.5–10) 9 (1.5–29) NS 10.8 (1.5–29) 6.2 (4–14) .03 
Neutrophil percentage 57 (42.9–76) 76.5 (3–92.1) .0 0 01 72 (3–92.1) 78 (62–90) NS 
Monocyte percentage 3 (2–9.3) 2 (0–7) NS 2 (0–7) 2 (1–4) NS 
Lymphocyte percentage 35.5 (20–50) 19 (1–36) .0 0 01 1 (1–36) 20 (8–35) NS 
Death, no. (%) of patients 0 (0) 1 (3.7) – 1 (6.3) 0 (0) NS 
All values are reported as median value mean (range) unless stated otherwise. NS: not signiﬁcant; WBC: white blood cell count. 
a comparison between healthy controls and typhoid fever patients. 
b comparison between culture negative/PCR + and culture positive patients. 
c Normal range, not measured in the control group. 
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i  normalized ratio (APCsr) was determined by dividing the APCsr of
an individual by the APCsr of the pooled plasma (a ratio > 1.6 re-
ﬂects an APC resistant phenotype). DIC scores were calculated us-
ing the International Society on Thrombosis and Hemostasis (ISTH)
standardized method. 21 
Statistical analysis 
A primary analysis was performed in which results for con-
trol subjects and patients with typhoid fever were compared. Sub-
group analysis was performed to compare results from patients
with blood culture-positive for S. Typhi species with those from
culture-negative but PCR positive patients and to compare results
from patients with complicated disease with those from patients
with uncomplicated disease. 
Data on patient’s characteristics and laboratory results were
compared between different groups using student’s t-test or Mann-
hitney U for continuous variables, and the χ2 test or Fisher’s
exact test for categorical variables as appropriate. Correlations
were calculated using the Spearman rho test. All analyses were
performed using Graphpad prism, version 6 for Mac (Graphpad
Software). 
Results 
Patients 
A total of 144 consecutive patients with fever admitted to the
hospital were enrolled in this study, of which 28 had conﬁrmed
typhoid fever (19.4%). Of these conﬁrmed typhoid fever cases, 11
(39%) were diagnosed by isolation of S. Typhi from blood, and 17
(61%) by positive S. Typhi PCR in blood (15), urine (2) and/or feces
(1). Thirty-eight healthy local volunteers served as controls. Base-
line clinical features are shown in Table 1 . Patients with typhoid
fever had signiﬁcantly lower median platelet counts than the con-
trol group ( P < .0 0 01; Fig. 1 A). There was one death (3.7%) due to
septic shock in the group of patients who were S. Typhi culture-
negative but S. Typhi blood PCR-positive. ctivation of coagulation in typhoid fever 
In patients with typhoid fever, coagulation was signiﬁcantly en-
anced as reﬂected by elevated plasma concentrations of F1 + 2
nd D-dimer when compared to healthy controls ( P < .0 0 01 for
oth comparisons; Fig. 1 B and C). Fibrinogen levels were strongly
levated in patients versus controls ( P < .0 0 01; Fig. 1 D). In ad-
ition, both PT and APTT were prolonged in patients compared
o controls, suggesting an increased consumption of clotting fac-
ors ( P < .01–0.0 0 01; Fig. 1 E and F). The observed differences in
1 + 2, D-dimer, ﬁbrinogen, PT and APTT were preserved in sub-
roup analyses, in which culture-negative but PCR-positive and
ulture-positive groups were compared separately against the con-
rols ( Fig. 1 ). To further investigate the functionality of the de-
ected coagulation activation, we analyzed the coagulation poten-
ial of plasma induced by tissue factor by calibrated automated
hrombinography (CAT, Fig. 2 A). 18 , 20 In typhoid fever patients, the
ag-time was signiﬁcantly prolonged in comparison to the con-
rols, which is in line with the observed prolonged PTs ( P < .0 0 01;
ig. 2 B). The peak thrombin ( Fig. 2 C) and velocity index (data not
hown) had higher median levels in patients which could be a di-
ect result of affected anticoagulant pathways, since antithrombin
s an important determinant of CAT. 20 The area-under-the-curve
or ETP) did not differ between typhoid and controls suggesting
hat despite delayed coagulation initiation, the amount of throm-
in and thus clots that can be formed during typhoid fever is sim-
lar between groups ( Fig. 2 D). In the subgroup analyses, culture-
egative and PCR-positive patients had higher peak thrombin lev-
ls and higher median ETP compared to controls, implying that
his subgroup have a greater ability to generate thrombin ( P < .05;
ig. 2 ). 
ctivation of the vascular endothelium 
During acute inﬂammation, the endothelium becomes activated,
hich contributes to the attraction of leukocytes and formation
f a thrombus. 22 , 23 Recent preclinical work has shown that S.
yphi exotoxin interacts with podocalyxin-like protein-1 which
ocalizes to the apical side of epithelial cells and is expressed
n vascular endothelial cells. 12 We found strong endothelium
H.K. de Jong et al. / Journal of Infection 77 (2018) 60–67 63 
Fig. 1. Activation of coagulation. 
Coagulation factors (Platelets, A; Prothrombin fragment 1 + 2, B; D-dimer, C; Fibrinogen, D; Prothrombin time, E; Activated partial thromboplastin time, F) in patients with 
typhoid fever (empty squares) who were culture positive (black triangles) or culture negative (empty triangles) for S. Typhi and in healthy Bangladeshi control subjects 
(empty circles). Data are expressed as dot plots with medians. 
F1 + 2: prothrombin fragment 1 + 2; PT: prothrombin time; APTT: activated partial thromboplastin time. 
Fig. 2. In vitro thrombin generation. 
In vitro thrombin generation (thrombin generation assay, A; Lag time, B; Peak thrombin, C; Endogenous thrombin potential, D) assessed in typhoid fever patients (empty 
squares) who were culture positive (black triangles) or culture negative (empty triangles) for S. Typhi and of healthy Bangladeshi control subjects (empty circles). Data are 
expressed as dot plots with medians. 
ETP: endogenous thrombin potential. 
64 H.K. de Jong et al. / Journal of Infection 77 (2018) 60–67 
Fig. 3. Activation of vascular endothelium. 
Activation of the endothelium (von Willebrand factor, A; Endothelial cell speciﬁc molecule-1, C) in patients with typhoid fever (empty squares) who were culture positive 
(black triangles) or culture negative (empty triangles) for S. Typhi and in healthy Bangladeshi control subjects (empty circles). Data are expressed as dot plots with medians. 
Correlation curve platelet count versus von Willebrand factor (B). P -value and Spearman Rho, linear regression analysis. 
VWF: von Willebrand factor; ESM-1/Endocan: endothelial cell speciﬁc molecule-1. 
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reﬂected by increased levels of VWF, a large multimer secreted by
endothelial cells following stimulation by among others endotoxin,
cytokines or thrombin ( P < .0 0 01; Fig. 3 A). 18 , 24 VWF plays a key
role in platelet adhesion and aggregation and observed low platelet
counts in typhoid fever patients strongly correlated with VWF con-
centrations ( r = −0.41, P < .001; Fig. 3 B). Further evidence of acti-
vation of vascular endothelium was provided by measurements of
endocan, a newly described soluble proteoglycan expressed by en-
dothelial cells and which expression relates with severity of illness
in patients with sepsis. 25 Endocan was elevated in patients when
compared to controls; subgroup analyses showed that endocan lev-
els in the culture-positive group were higher than in the culture-
negative PCR-positive patients ( P < .0 0 01; Fig. 3 C). 
Downregulation of anticoagulant pathways 
Coagulation activation in patients with typhoid fever was paral-
leled with a depression of anticoagulation pathways: AT and pro-
tein C concentrations were decreased and APC-sensitivity ratios
were increased in patients compared to healthy controls ( P < .05,
P < .0 0 01 and P < .01 respectively; Fig. 4 A–C). Total (and free, data
not shown) protein S levels were not different in patients com-
pared to controls ( Fig. 4 D). 
Activation and inhibition of ﬁbrinolysis 
Patients with typhoid fever demonstrated evidence of activa-
tion and inhibition of ﬁbrinolysis, as reﬂected by elevated plasma
levels of tPA and PAI-1 ( P < .05 , and P < .01 respectively; Fig. 5 A
and B). In addition, patients showed strongly increased PAPc when
compared to healthy subjects ( P < .001; Fig. 5 C). Levels of su-
PAR, an important soluble mediator of ﬁbrinolysis that is pro-
posed as a potential prognostic biomarker for sepsis, 26 , 27 were
signiﬁcantly higher in patients compared to controls ( P < .0 0 01;
Fig. 5 D). To assess coagulation–ﬁbrinolysis (im)balance we assessed
DIC scores which were strongly increased in patients compared to
controls, with 5 patients (18%) having a DIC score ≥5. These differ-
ences were preserved in the subgroup analysis, in which culture-
negative and culture-positives were compared separately with con-
trols ( P < .0 0 01; Fig. 5 E). 
Association between coagulation abnormalities and severity of disease
Having characterized the spectrum of coagulation activation in
typhoid fever, we next sought to examine associations between the
coagulation proﬁle and clinical severity. Eleven (39%) patients werelassiﬁed as having complicated typhoid fever. Speciﬁc complica-
ions were: pneumonia (3); encephalopathy (2); gastrointestinal
leeding (1); severe anemia requiring blood transfusion (1); acute
epatitis (1); hepatic abscess (1); septic arthritis (1); and renal fail-
re, cardiopulmonary arrest and death (1). Having a positive blood
ulture did not result in a higher risk of developing a complication
n this study, only 2 out 8 patients with a positive blood culture
eveloped a complication. Fibrinogen levels were signiﬁcantly ele-
ated in patients with complicated typhoid fever when compared
o patients with uncomplicated typhoid fever (median (IQR); 7.4
5–7) vs 4.7 (4–5), P < .01). Other measured abnormalities in co-
gulation, anti-coagulation and ﬁbrinolysis or endothelium activa-
ion were not associated with the presence of complications (data
ot shown). The extent of coagulation activation correlated with
he stage of the disease; most measured markers showed com-
lete (APTT, endocan, protein C; P < .01–0.05; Fig. 6 (mean with
5% CI) or near complete normalization (F1 + 2, D-dimer, ﬁbrino-
en, PT, PAI-1 and suPAR; data not shown) in patients from whom
ollow-up samples were available at discharge. Plasma levels of
WF and PAPc were not yet normalized at time of discharge (data
ot shown). Furthermore, in patients the platelet count – but not
hite blood cell count - negatively correlated with almost all co-
gulation and ﬁbrinolysis markers ( P < .05; except for ﬁbrinogen,
 = .06) and positively correlated with the natural anticoagulant
rotein C ( P < .0 0 01). 
iscussion 
Different forms of bleeding have been described in typhoid
ever, either self-limiting local hemorrhage in the gastrointestinal
ract due to inﬂammation or generalized bleeding as a result of im-
alance in the activation of coagulation. 28 In the present study, we
emonstrate that the coagulation system is markedly activated in
lmost all patients involving all three major pathways: procoagu-
ant, anticoagulant, and ﬁbrinolytic. These results shed light on the
otential mechanisms responsible for the different forms of bleed-
ng observed in these patients. 
Our data point to an overall prothrombotic state in typhoid
ever. Patients demonstrated increased plasma prothrombin frag-
ents as well as ﬁbrin degradation products and lower protein
 and AT concentrations than healthy controls. The ability to
enerate thrombin in vitro was partially delayed in patients con-
rming the prolonged PT, but patients were capable of generat-
ng higher amounts of thrombin, which is most likely the result
f the affected anticoagulation pathways, as these are impor-
ant determinants of in vitro thrombin generation. 20 Moreover,
IC scores, which provide insight into the coagulation–ﬁbrinolysis
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Fig. 4. Anticoagulation. 
Anticoagulant factors (Antithrombin, A; Protein C, B; Activated protein C sensitivity ratio, C; Total protein S, D) in patients with typhoid fever (empty squares) who were 
culture positive (black triangles) or culture negative (empty triangles) for S. Typhi and in healthy Bangladeshi control subjects (empty circles). Data are expressed as dot 
plots with medians. AT: antithrombin; APC: activated protein C. 
Fig. 5. Activation and inhibition of ﬁbrinolysis. 
Activation and inhibition (Tissue-type plasminogen activator, A; Plasminogen activator inhibitor type, B; Plasmin-alpha2-antiplasmin complexes, C; Soluble form of the 
urokinase-type plasminogen activator receptor, D; Disseminated intravascular coagulation, E) of ﬁbrinolysis in patients with typhoid fever (empty squares) who were culture 
positive (black triangles) or culture negative (empty triangles) for S. Typhi and in healthy Bangladeshi control subjects (empty circles). Data are expressed as dot plots with 
medians. Data are expressed as dot plots with medians. 
tPA: tissue-type plasminogen activator; PAI-1: plasminogen activator inhibitor type; PAPc: plasmin-alpha2-antiplasmin complexes; suPAR: soluble form of the urokinase-type plas- 
minogen activator receptor; DIC: disseminated intravascular coagulation. 
66 H.K. de Jong et al. / Journal of Infection 77 (2018) 60–67 
Fig. 6. Association between coagulation abnormalities and severity of disease. 
The normalization of three parameters (Activated partial thromboplastin time, A; Endothelial cell speciﬁc molecule-1, B; Protein C, C) over time in typhoid fever patients 
( n = 16 patients). The time points are day of enrollment, and day of discharge (mean with 95% CI). Dotted line represents reference values of healthy controls. 
APTT: activated partial thromboplasmin time; ESM-1/Endocan: endothelial cell speciﬁc molecule-1 . 
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9(im)balance, 8 were markedly elevated in the majority of typhoid
fever patients. Furthermore, in this study we were able to collect
samples from patients on day of admission and on day of dis-
charge, which gave us a further insight into the course of disease.
The extent of coagulation activation correlated with the course of
disease, most measured markers showed complete or near nor-
malization during convalescence. However, samples were only col-
lected acutely and at time of hospital discharge - there are mul-
tiple other factors apart from disease progression, which may ac-
count for these differences such as use of antibiotics. 
Fibrinolysis was grossly activated in our cohort of patients as
shown by increased tPA and PAPc levels. In addition, our data
on reduced expression of anticoagulant mechanisms are consistent
with previous investigations reporting low circulating levels of pro-
tein C and AT in typhoid fever, 28 , 29 which could, in part, contribute
to the development of DIC. Of note, protein C becomes activated
by the thrombin-thrombomodulin complex. In a previous study, an
increase in soluble thrombomodulin was found in patients with ty-
phoid fever. 30 One would hypothesise that increased levels of sol-
uble thrombomodulin would lead to elevated levels of thrombin-
trombomodulin complexes and enhanced consumption of protein
C. In addition, we found an APC resistant phenotype. APC is an
anticoagulant as it inactivates factors Va and VIIIa. Reduced sen-
sitivity for APC, caused by for instance a factor V Leiden muta-
tion, is a well-established risk factor for the development of ve-
nous thrombosis. 31 We now demonstrate that patients with ty-
phoid fever patients have decreased plasma protein C concentra-
tions together with an APC-resistant phenotype. 
Our study design uniquely enabled us to compare markers of
coagulation and ﬁbrinolysis in blood culture-positive and culture-
negative/PCR-positive patients in the same population in order to
generate future hypotheses. Therefore no adjustments were made
for multiple comparisons. We demonstrate that virtually all mea-
sured markers are signiﬁcantly affected by typhoid fever and there
was a trend to more pronounced activation of coagulation, ﬁbrinol-
ysis and endothelium with concurrent impaired of anticoagulant
pathways in the blood culture-positive group when compared to
the culture-negative/PCR-positive patients. The presence of bacteria
in the systemic compartment could contribute to this phenomenon
due to increased shedding of endotoxin and/or the recently dis-
covered S. Typhi exotoxin. 12 Endotoxin has previously been sug-
gested to be the prime mediator of the hematologic changes ob-
served in typhoid patients 11 , 32 and indeed is a known potent in-
ducer of coagulation. 22 , 24 Its role as a virulence factor in typhoid
fever however is debatable as S. Typhi’s Vi capsule can prevent en-
dotoxin recognition by the host. 2 , 33 In addition, endotoxins could
not be detected in typhoid fever patients with severe DIC. 11 The
exotoxin of S. Typhi can, however, interact with the vascular en-
dothelium 12 and perhaps contributes to the signs and symptoms
of typhoid fever. We now observe that markers of endothelial ac-ivation, most notably VWF and endocan, are sharply increased in
he blood culture-positive group when compared to the culture-
egative/PCR-positive group. However, the signiﬁcance of the ac-
ivation of coagulation, ﬁbrinolysis, and concurrent downregula-
ion of the anticoagulation, is limited by the lack of a non-typhoid
ebrile control group, which calls into question whether this is a
yphoid-speciﬁc phenomenon. 
Acute infection can result in systemic activation of coagula-
ion. 22 , 24 One could postulate that in typhoid fever the activation
f coagulation and deposition of ﬁbrin as a consequence of inﬂam-
ation can be considered instrumental in containing inﬂammatory
ctivity. Immunologic functions of thrombi are critically depen-
ent on platelets. 23 In our study, 18% of typhoid fever patients had
arked thrombocytopenia and most measured markers for coagu-
ation negatively correlated with platelet count. The mechanism of
hrombocytopenia in typhoid fever remains ill deﬁned. It has been
ostulated that defects in the production of platelets are caused
y a direct toxic effect of Salmonella on the bone marrow, 34 while
thers have suggested non-immune platelet destruction to be an
ffect of DIC. 23 , 35 More recent insights indicate that the abundant
resence of hemophagocytes during Salmonella infections, which
re important for intracellular replication and thus maintenance of
hronic infection, could in part explain the low platelet – as well
s leukocyte – counts commonly seen in typhoid fever. 36 
In summary, our data show that acute typhoid fever is char-
cterized by activation of coagulation and endothelium, activation
nd inhibition of ﬁbrinolysis and concurrent impairment of antico-
gulant mechanisms. The clinical importance of our ﬁndings is un-
erscored by the association between the observed disturbances in
he coagulation cascade and the course of disease. Repeated testing
uring convalescence showed a return toward normal values. 
cknowledgments 
We thank Wahid Rahman, Murad Hero and Naﬁz Iqbal who
ecruited patients during the study period; Marian Weijne, Wil
opatz, Lucy Leverink, Suman, Sanjeeb and staff from Chevron
td. for laboratory support; Shaﬁqul Chowdhurry for administrative
upport; Richard J. Maude, Kees van ’t Veer, Alex de Vos, and Ar-
an J. Hoogendijk for helpful discussions and Tom van der Poll for
ritically reading the manuscript. We thank the nurses and doctors
t Chittagong Medical College Hospital, Chittagong, who were re-
ponsible for providing all care for the patients in the study. 
HKdJ received unrestricted funding for this project from the
cademic Medical Center (AMC PhD Scholarship). WJW: The
etherlands Organisation for Scientiﬁc Research (NWO; VENI grant
o. 91610 0 08 ) and The Netherlands Organisation for Health Re-
earch and Development (ZonMw; Clinical Fellowship grant no.
0700424 ). 
H.K. de Jong et al. / Journal of Infection 77 (2018) 60–67 67 
R
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2  
 
 
 
 
2  
 
2  
2  
2  
 
2  
 
 
 
2  
 
2  
 
3  
 
 
3  
 
3
 
3  
 
3  
 
3  eferences 
1. Crump JA , Mintz ED Global trends in typhoid and paratyphoid fever. Clin Infect
Dis 2010; 50 (2):241–6 . 
2. de Jong HK , Parry CM , van der Poll T , Wiersinga WJ Host-pathogen interac-
tion in invasive salmonellosis. PLoS Pathog 2012; 8 (10):e1002933 PubMed PMID:
23055923. eng . 
3. Mogasale V , Maskery B , Ochiai RL , Lee JS , Mogasale VV , Ramani E , et al. Bur-
den of typhoid fever in low-income and middle-income countries: a system-
atic, literature-based update with risk-factor adjustment. Lancet Glob Health
2014; 2 (10):e570–80 PubMed PMID: 25304633 . 
4. Lima A , Guerrant RL Inﬂammatory enteritides. Principles and practice of infec-
tious diseases . Mandell G, Bennett JE, Dolin R, editors. 7th ed. Churchill Living-
stone: Elsevier; 2009 . 
5. Rowland HA The complications of typhoid fever. J Trop Med Hyg 1961; 64 :143–52
PubMed PMID: 13744157 . 
6. Mogasale V , Desai SN , Mogasale VV , Park JK , Ochiai RL , Wierzba TF Case fa-
tality rate and length of hospital stay among patients with typhoid intestinal
perforation in developing countries: a systematic literature review. PLoS One
2014; 9 (4):e93784 PubMed PMID: 24743649 . 
7. Parry CM , Hien TT , Dougan G , White NJ , Farrar JJ Typhoid fever. N Engl J Med
2002; 347 (22):1770–82 PubMed PMID: 12456854. Epub 2002/11/29. eng . 
8. Levi M , Ten Cate H Disseminated intravascular coagulation. N Engl J Med
1999; 341 (8):586–92 PubMed PMID: 10451465 . 
9. Khan M , Coovadia Y , Connolly C , Sturm AW Risk factors predicting compli-
cations in blood culture-proven typhoid fever in adults. Scand J Infect Dis
20 0 0; 32 (2):201–5 PubMed PMID: 10826909. Epub 20 0 0/05/29. eng . 
10. Hermans P , Gerard M , van Laethem Y , de Wit S , Clumeck N Pancreatic distur-
bances and typhoid fever. Scand J Infect Dis 1991; 23 (2):201–5 PubMed PMID:
1712981. Epub 1991/01/01. eng . 
11. Butler T , Bell WR , Levin J , Linh NN , Arnold K Typhoid fever. Studies of blood
coagulation, bacteremia, and endotoxemia. Arch Intern Med 1978; 138 (3):407–10
PubMed PMID: 629635 . 
12. Song J , Gao X , Galan JE Structure and function of the Salmonella Typhi chi-
maeric A(2)B(5) typhoid toxin. Nature 2013; 499 (7458):350–4 PubMed PMID:
23842500 . 
13. Maude RR , Ghose A , Samad R , de Jong HK , Fukushima M , Wijedoru L , et al. A
prospective study of the importance of enteric fever as a cause of non-malar-
ial febrile illness in patients admitted to Chittagong Medical College Hospital,
Bangladesh. BMC Infect Dis 2016; 16 (1):567 PubMed PMID: 27737634 . 
14. de Jong HK , Garcia-Laorden MI , Hoogendijk AJ , Parry CM , Maude RR , Don-
dorp AM , et al. Expression of intra- and extracellular granzymes in patients
with typhoid fever. PLoS Negl Trop Dis 2017; 11 (7):e0 0 05823 PubMed PMID:
28749963 . 
15. Maude RR , de Jong HK , Wijedoru L , Fukushima M , Ghose A , Samad R , et al. The
diagnostic accuracy of three rapid diagnostic tests for typhoid fever at Chit-
tagong Medical College Hospital, Chittagong, Bangladesh. Trop Med Int Health
2015; 20 (10):1376–84 PubMed PMID: 26094960 . 
16. Nga TV , Karkey A , Dongol S , Thuy HN , Dunstan S , Holt K , et al. The sensitivity of
real-time PCR ampliﬁcation targeting invasive Salmonella serovars in biological
specimens. BMC Infect Dis 2010; 10 :125 PubMed PMID: 20492644 . 
17. Wiersinga WJ , Meijers JC , Levi M , Van ’t Veer C , Day NP , Peacock SJ , et al. Ac-
tivation of coagulation with concurrent impairment of anticoagulant mecha-
nisms correlates with a poor outcome in severe melioidosis. J Thromb Haemost
2008; 6 (1):32–9 PubMed PMID: 17944999 . 18. Koh GC , Meijers JC , Maude RR , Limmathurotsakul D , Day NP , Peacock SJ ,
et al. Diabetes does not inﬂuence activation of coagulation, ﬁbrinolysis or an-
ticoagulant pathways in Gram-negative sepsis (melioidosis). Thromb Haemost
2011; 106 (6):1139–48 PubMed PMID: 21979378. Epub 2011/10/08. eng . 
19. Lowenberg EC , Charunwatthana P , Cohen S , van den Born BJ , Meijers JC ,
Yunus EB , et al. Severe malaria is associated with a deﬁciency of von Wille-
brand factor cleaving protease, ADAMTS13. Thromb Haemost 2010; 103 (1):181–7
PubMed PMID: 20062916 . 
0. Hemker HC , Beguin S Thrombin generation in plasma: its assessment via the
endogenous thrombin potential. Thromb Haemost 1995; 74 (1):134–8 PubMed
PMID: 8578446 . 
21. Voves C , Wuillemin WA , Zeerleder S International Society on Thrombosis and
Haemostasis score for overt disseminated intravascular coagulation predicts
organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis
2006; 17 (6):445–51 PubMed PMID: 16905947 . 
2. Schouten M , Wiersinga WJ , Levi M , van der Poll T Inﬂammation, endothe-
lium, and coagulation in sepsis. J Leukoc Biol 2008; 83 (3):536–45 PubMed PMID:
18032692 . 
3. Engelmann B , Massberg S Thrombosis as an intravascular effector of innate im-
munity. Nat Rev Immunol 2013; 13 (1):34–45 PubMed PMID: 23222502 . 
4. Levi M , van der Poll T Inﬂammation and coagulation. Crit Care Med 2010; 38 (2
Suppl):S26–34 PubMed PMID: 20083910 . 
5. Scherpereel A , Depontieu F , Grigoriu B , Cavestri B , Tsicopoulos A , Gentina T ,
et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med
2006; 34 (2):532–7 PubMed PMID: 16424738 . 
6. Donadello K , Scolletta S , Covajes C , Vincent JL suPAR as a prognostic biomarker
in sepsis. BMC Med 2012; 10 :2 PubMed PMID: 22221662 . 
27. Wittenhagen P , Kronborg G , Weis N , Nielsen H , Obel N , Pedersen SS , et al. The
plasma level of soluble urokinase receptor is elevated in patients with Strep-
tococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect
2004; 10 (5):409–15 PubMed PMID: 15113317 . 
8. Spencer DC , Pienaar NL , Atkinson PM Disturbances of blood coagulation as-
sociated with Salmonella typhi infections. J Infect 1988; 16 (2):153–61 PubMed
PMID: 3351316 . 
9. Koul PA , Quadri MI , Wani JI , Wahid A , Shaban M Haemostatic abnormalities
in multidrug-resistant enteric fever. Acta Haematol 1995; 93 (1):13–19 PubMed
PMID: 7725844 . 
0. Ohnishi K , Kimura K Serum thrombomodulin levels in patients with typhoid
fever. Trans R Soc Trop Med Hyg 1998; 92 (3):320–1 PubMed PMID: 9861408 . 
31. Bertina RM , Koeleman BP , Koster T , Rosendaal FR , Dirven RJ , de Ronde H ,
et al. Mutation in blood coagulation factor V associated with resistance to acti-
vated protein C. Nature 1994; 369 (6475):64–7 PubMed PMID: 8164741 . 
2. Colman RW , Edelman R , Scott CF , Gilman RH Plasma kallikrein activation and
inhibition during typhoid fever. J Clin Invest 1978; 61 (2):287–96 PubMed PMID:
74379 . 
3. Wilson RP , Raffatellu M , Chessa D , Winter SE , Tukel C , Baumler AJ The Vi–
capsule prevents Toll-like receptor 4 recognition of Salmonella . Cell Microbiol
2008; 10 (4):876–90 . 
4. Serefhanoglu K , Kaya E , Sevinc A , Aydogdu I , Kuku I , Ersoy Y Isolated
thrombocytopenia: the presenting ﬁnding of typhoid fever. Clin Lab Haematol
2003; 25 (1):63–5 PubMed PMID: 12542445 . 
5. James J , Dutta TK , Jayanthi S Correlation of clinical and hematologic pro-
ﬁles with bone marrow responses in typhoid fever. Am J Trop Med Hyg
1997; 57 (3):313–16 PubMed PMID: 9311642 . 
6. Silva-Herzog E , Detweiler CS Intracellular microbes and haemophagocytosis. Cell
Microbiol 2008; 10 (11):2151–8 PubMed PMID: 18616693 . 
